ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer

por Bill, Anke, Gutierrez, Abraham, Kulkarni, Sucheta, Kemp, Carolyn, Bonenfant, Debora, Voshol, Hans, Duvvuri, Umamaheswar, Gaither, L. Alex
Publicado 2015

The Pseudophosphatase MK-STYX Physically and Genetically Interacts with the Mitochondrial Phosphatase PTPMT1

por Niemi, Natalie M., Sacoman, Juliana L., Westrate, Laura M., Gaither, L. Alex, Lanning, Nathan J., Martin, Katie R., MacKeigan, Jeffrey P.
Publicado 2014

Small Molecule-facilitated Degradation of ANO1 Protein: A NEW TARGETING APPROACH FOR ANTICANCER THERAPEUTICS

por Bill, Anke, Hall, Michelle Lynn, Borawski, Jason, Hodgson, Catherine, Jenkins, Jeremy, Piechon, Philippe, Popa, Oana, Rothwell, Christopher, Tranter, Pamela, Tria, Scott, Wagner, Trixie, Whitehead, Lewis, Gaither, L. Alex
Publicado 2014

High Throughput Mutagenesis for Identification of Residues Regulating Human Prostacyclin (hIP) Receptor Expression and Function

por Bill, Anke, Rosethorne, Elizabeth M., Kent, Toby C., Fawcett, Lindsay, Burchell, Lynn, van Diepen, Michiel T., Marelli, Anthony, Batalov, Sergey, Miraglia, Loren, Orth, Anthony P., Renaud, Nicole A., Charlton, Steven J., Gosling, Martin, Gaither, L. Alex, Groot-Kormelink, Paul J.
Publicado 2014